Enter the first few characters of Company and click 'Go'
Audited Results of Marksans Pharma Ltd. Company
(Rs in Cr.) |
Mar 31, 2023 |
Mar 31, 2022 |
Mar 31, 2021 |
Mar 31, 2020 |
Mar 31, 2019 |
Operating Income |
655.20 |
658.29 |
599.55 |
433.42 |
424.16 |
Manufacturing Expenses |
14.24 |
11.27 |
10.90 |
8.95 |
8.22 |
Personnel Expenses |
56.09 |
60.46 |
54.64 |
48.51 |
46.33 |
Selling Expenses |
0 |
0 |
0 |
0 |
0 |
Administrative Expenses |
98.52 |
95.25 |
82.38 |
61.43 |
69.94 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Cost Of Sales |
563.30 |
544.57 |
485.84 |
361.93 |
360.83 |
Operating Profit |
91.90 |
113.72 |
113.71 |
71.49 |
63.33 |
Other Recurring Income |
60.48 |
42.25 |
31.16 |
0.17 |
7.93 |
Adjusted PBDIT |
152.38 |
155.97 |
144.87 |
71.66 |
71.26 |
Financial Expenses |
3.61 |
3.79 |
5.34 |
7.29 |
6.56 |
Depreciation |
16.74 |
17.66 |
15.19 |
11.64 |
8.69 |
Other Write offs |
0 |
0 |
0 |
0 |
0 |
Adjusted PBT |
132.03 |
134.51 |
124.33 |
52.73 |
56.01 |
Tax Charges |
29.17 |
30.52 |
25.95 |
14.82 |
12.39 |
Adjusted PAT |
102.87 |
103.99 |
98.38 |
37.90 |
43.62 |
Non Recurring Items |
-0.59 |
0.05 |
-0.20 |
0.16 |
0.03 |
Other Non Cash adjustments |
0 |
0 |
0 |
0 |
0 |
Reported Net Profit |
102.87 |
103.99 |
98.38 |
37.90 |
43.62 |
Equity Dividend |
10.17 |
10.23 |
4.09 |
2.47 |
2.05 |
Preference Dividend |
0 |
0 |
0 |
0 |
0 |
Retained Earnings |
247.31 |
155.21 |
61.41 |
-27.14 |
-62.74 |